Arrivé, C.; Jacquet, M.; Gautier-Veyret, E.; Jouve, T.; Noble, J.; Lombardo, D.; Rostaing, L.; Stanke-Labesque, F.
Early Exposure of Kidney Transplant Recipients with Chronic Antibody-Mediated Rejection to Tocilizumab—A Preliminary Study. J. Clin. Med. 2023, 12, 7141.
https://doi.org/10.3390/jcm12227141
AMA Style
Arrivé C, Jacquet M, Gautier-Veyret E, Jouve T, Noble J, Lombardo D, Rostaing L, Stanke-Labesque F.
Early Exposure of Kidney Transplant Recipients with Chronic Antibody-Mediated Rejection to Tocilizumab—A Preliminary Study. Journal of Clinical Medicine. 2023; 12(22):7141.
https://doi.org/10.3390/jcm12227141
Chicago/Turabian Style
Arrivé, Capucine, Marvin Jacquet, Elodie Gautier-Veyret, Thomas Jouve, Johan Noble, Dorothée Lombardo, Lionel Rostaing, and Françoise Stanke-Labesque.
2023. "Early Exposure of Kidney Transplant Recipients with Chronic Antibody-Mediated Rejection to Tocilizumab—A Preliminary Study" Journal of Clinical Medicine 12, no. 22: 7141.
https://doi.org/10.3390/jcm12227141
APA Style
Arrivé, C., Jacquet, M., Gautier-Veyret, E., Jouve, T., Noble, J., Lombardo, D., Rostaing, L., & Stanke-Labesque, F.
(2023). Early Exposure of Kidney Transplant Recipients with Chronic Antibody-Mediated Rejection to Tocilizumab—A Preliminary Study. Journal of Clinical Medicine, 12(22), 7141.
https://doi.org/10.3390/jcm12227141
